Monopar Therapeutics Inc
NASDAQ:MNPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
US |
|
Calian Group Ltd
TSX:CGY
|
CA |
Multiples-Based Value
The Multiples-Based Value for
Monopar Therapeutics Inc (MNPR) under the Base Case is 39.6 USD.
Compared with the current market price of 59.48 USD, the stock appears
Overvalued by 33% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.